These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15965590)

  • 21. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate.
    Huynh TT; Padois K; Sonvico F; Rossi A; Zani F; Pirot F; Doury J; Falson F
    Eur J Pharm Biopharm; 2010 Feb; 74(2):255-64. PubMed ID: 19909814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer.
    Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC
    Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of drug delivery systems controlled by dissolution of the polymer carrier.
    Narasimhan B; Peppas NA
    J Pharm Sci; 1997 Mar; 86(3):297-304. PubMed ID: 9050796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid-state NMR studies of pharmaceutical solids in polymer matrices.
    Lubach JW; Padden BE; Winslow SL; Salsbury JS; Masters DB; Topp EM; Munson EJ
    Anal Bioanal Chem; 2004 Mar; 378(6):1504-10. PubMed ID: 15214410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled release of pranoprofen from the ethylene-vinyl acetate matrix using plasticizer.
    Cho CW; Choi JS; Shin SC
    Drug Dev Ind Pharm; 2007 Jul; 33(7):747-53. PubMed ID: 17654023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices.
    Genina N; Holländer J; Jukarainen H; Mäkilä E; Salonen J; Sandler N
    Eur J Pharm Sci; 2016 Jul; 90():53-63. PubMed ID: 26545484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug release from starch-acetate microparticles and films with and without incorporated alpha-amylase.
    Tuovinen L; Peltonen S; Liikola M; Hotakainen M; Lahtela-Kakkonen M; Poso A; Järvinen K
    Biomaterials; 2004 Aug; 25(18):4355-62. PubMed ID: 15046926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of 5-fluorouracil-loaded ethylene-vinyl acetate stent coating based on percolation thresholds.
    Guo QH; Guo SR; Wang ZM
    Int J Pharm; 2007 Mar; 333(1-2):95-102. PubMed ID: 17110064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards Understanding the Chemical Structure Modification of EVA Copolymer upon MAPLE Processing of Thin Films.
    Niemczyk A; Brajnicov S; Satulu V; Baranowska J; Mitu B; Dinescu M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of diffusion of monosubstituted benzoic acids through ethylene-vinyl acetate copolymers.
    Maurin MB; Dittert LW; Hussain AA
    J Pharm Sci; 1992 Jan; 81(1):79-84. PubMed ID: 1619575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical characteristics of quinupramine in the EVA matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2006 Aug; 320(1-2):1-3. PubMed ID: 16844330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
    Ali R; Dashevsky A; Bodmeier R
    Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of supersaturation and crystallization phenomena on the release properties of a controlled release device based on EVA copolymer.
    van Laarhoven JA; Kruft MA; Vromans H
    J Control Release; 2002 Aug; 82(2-3):309-17. PubMed ID: 12175745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the Nb2O5 dispersion on ethylene vinyl acetate to obtain ethylene vinyl acetate/Nb2O5 nanostructured materials.
    Valentim AC; Tavares MI; da Silva EO
    J Nanosci Nanotechnol; 2013 Jun; 13(6):4427-32. PubMed ID: 23862516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release.
    Kapoor S; Hegde R; Bhattacharyya AJ
    J Control Release; 2009 Nov; 140(1):34-9. PubMed ID: 19654029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro release and characterization of chitosan films as dexamethasone carrier.
    Rodrigues LB; Leite HF; Yoshida MI; Saliba JB; Cunha AS; Faraco AA
    Int J Pharm; 2009 Feb; 368(1-2):1-6. PubMed ID: 18955123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound-triggered release from multilayered capsules.
    De Geest BG; Skirtach AG; Mamedov AA; Antipov AA; Kotov NA; De Smedt SC; Sukhorukov GB
    Small; 2007 May; 3(5):804-8. PubMed ID: 17385759
    [No Abstract]   [Full Text] [Related]  

  • 40. The Use of Cellulose Membrane to Eliminate Burst Release from Intravaginal Rings.
    Helbling IM; Ibarra JC; Luna JA
    AAPS J; 2016 Jul; 18(4):960-71. PubMed ID: 27097635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.